118 related articles for article (PubMed ID: 7950860)
1. Exploration of mucosal immunity in humans: relevance to vaccine development.
Czerkinsky C; Holmgren J
Cell Mol Biol (Noisy-le-grand); 1994; 40 Suppl 1():37-44. PubMed ID: 7950860
[TBL] [Abstract][Full Text] [Related]
2. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
[TBL] [Abstract][Full Text] [Related]
3. New perspectives in vaccine development: mucosal immunity to infections.
McGhee JR; Kiyono H
Infect Agents Dis; 1993 Apr; 2(2):55-73. PubMed ID: 8162356
[TBL] [Abstract][Full Text] [Related]
4. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans.
Mestecky J; Michalek SM; Moldoveanu Z; Russell MW
Behring Inst Mitt; 1997 Feb; (98):33-43. PubMed ID: 9382757
[TBL] [Abstract][Full Text] [Related]
5. Mucosal immunity: implications for vaccine development.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Immunobiology; 1992 Feb; 184(2-3):157-79. PubMed ID: 1587541
[TBL] [Abstract][Full Text] [Related]
6. Human circulating specific antibody-forming cells after systemic and mucosal immunizations: differential homing commitments and cell surface differentiation markers.
Quiding-Järbrink M; Lakew M; Nordström I; Banchereau J; Butcher E; Holmgren J; Czerkinsky C
Eur J Immunol; 1995 Feb; 25(2):322-7. PubMed ID: 7533081
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses.
Quiding-Järbrink M; Nordström I; Granström G; Kilander A; Jertborn M; Butcher EC; Lazarovits AI; Holmgren J; Czerkinsky C
J Clin Invest; 1997 Mar; 99(6):1281-6. PubMed ID: 9077537
[TBL] [Abstract][Full Text] [Related]
8. New generation of mucosal adjuvants for the induction of protective immunity.
Yuki Y; Kiyono H
Rev Med Virol; 2003; 13(5):293-310. PubMed ID: 12931340
[TBL] [Abstract][Full Text] [Related]
9. Mucosal responses to parenteral and mucosal vaccines.
Kaul D; Ogra PL
Dev Biol Stand; 1998; 95():141-6. PubMed ID: 9855424
[TBL] [Abstract][Full Text] [Related]
10. Induction of specific immunity at mucosal surfaces: prospects for vaccine development.
Czerkinsky C; Quiding M; Eriksson K; Nordström I; Lakew M; Wenerås C; Kilander A; Björck S; Svennerholm AM; Butcher E
Adv Exp Med Biol; 1995; 371B():1409-16. PubMed ID: 7502829
[TBL] [Abstract][Full Text] [Related]
11. Mucosal immunity: regulation by helper T cells and a novel method for detection.
Jackson RJ; Marinaro M; VanCott JL; Yamamoto M; Okahashi N; Fujihashi K; Kiyono H; Chatfield SN; McGhee JR
J Biotechnol; 1996 Jan; 44(1-3):209-16. PubMed ID: 8717406
[TBL] [Abstract][Full Text] [Related]
12. New perspectives in mucosal immunity with emphasis on vaccine development.
McGhee JR; Fujihashi K; Xu-Amano J; Jackson RJ; Elson CO; Beagley KW; Kiyono H
Semin Hematol; 1993 Oct; 30(4 Suppl 4):3-12; discussion 13-5. PubMed ID: 8303308
[TBL] [Abstract][Full Text] [Related]
13. Mucosal immunity in the female genital tract: relevance to vaccination efforts against the human immunodeficiency virus.
Mestecky J; Kutteh WH; Jackson S
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S11-20. PubMed ID: 7865284
[TBL] [Abstract][Full Text] [Related]
14. Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissues.
Imaoka K; Miller CJ; Kubota M; McChesney MB; Lohman B; Yamamoto M; Fujihashi K; Someya K; Honda M; McGhee JR; Kiyono H
J Immunol; 1998 Dec; 161(11):5952-8. PubMed ID: 9834076
[TBL] [Abstract][Full Text] [Related]
15. Oral immunization with simian immunodeficiency virus p55gag and cholera toxin elicits both mucosal IgA and systemic IgG immune responses in nonhuman primates.
Kubota M; Miller CJ; Imaoka K; Kawabata S; Fujihashi K; McGhee JR; Kiyono H
J Immunol; 1997 Jun; 158(11):5321-9. PubMed ID: 9164952
[TBL] [Abstract][Full Text] [Related]
16. Mucosal immunity of nasopharynx: an experimental study in TCR-transgenic (OVA23-3) mice.
Yamada T; Kataoka S; Ogasawara K; Ishimitsu R; Hashigucci K; Suzuki T; Kawauchi H
Rhinology; 2005 Sep; 43(3):190-8. PubMed ID: 16218512
[TBL] [Abstract][Full Text] [Related]
17. The immunologic aspects of human immunodeficiency virus infection in the gastrointestinal tract.
Schneider T; Ullrich R; Zeitz M
Semin Gastrointest Dis; 1996 Jan; 7(1):19-29. PubMed ID: 8903576
[TBL] [Abstract][Full Text] [Related]
18. Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production.
Yanagita M; Hiroi T; Kitagaki N; Hamada S; Ito HO; Shimauchi H; Murakami S; Okada H; Kiyono H
J Immunol; 1999 Mar; 162(6):3559-65. PubMed ID: 10092814
[TBL] [Abstract][Full Text] [Related]
19. In defense of mucosal surfaces. Development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens.
McGhee JR; Mestecky J
Infect Dis Clin North Am; 1990 Jun; 4(2):315-41. PubMed ID: 2189002
[TBL] [Abstract][Full Text] [Related]
20. Live varicella vaccine polarizes the mucosal adjuvant action of cholera toxin or its B subunit on specific Th1-type helper T cells with a single nasal coadministration in mice.
Sasaki K; Kato M; Takahashi T; Ochi S; Ichinose Y; Shiraki K; Asano Y; Iwanaga M; Tsuji T
J Med Virol; 2003 Jun; 70(2):329-35. PubMed ID: 12696126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
